MedPath

MICHAEL A NAUCK

πŸ‡ΊπŸ‡ΈUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Feed-Back Suppression of Meal-Induced Glucagon-like Peptide 1 (GLP-1) Secretion

Phase 1
Completed
Conditions
Type 2 Diabetes
Interventions
Other: Mixed meal test
Drug: Placebo
Other: Diet and exercise
First Posted Date
2016-04-22
Last Posted Date
2016-04-22
Lead Sponsor
Michael A. Nauck
Target Recruit Count
24
Registration Number
NCT02749032
Locations
πŸ‡©πŸ‡ͺ

Diabeteszentrum Bad Lauterberg, Bad Lauterberg, Niedersachsen, Germany

Carbohydrates to Prevent Hypoglycaemia During Physical Activity in Patients With Type 1 Diabetes

Not Applicable
Completed
Conditions
Hypoglycaemia
Interventions
Other: Rapid-acting carbohydrates
Other: low amount of carbohydrates
Other: high amount of carbohydrates
First Posted Date
2014-02-07
Last Posted Date
2014-02-07
Lead Sponsor
Michael A. Nauck
Target Recruit Count
37
Registration Number
NCT02057848
Locations
πŸ‡©πŸ‡ͺ

Diabeteszentrum, Bad Lauterberg, Germany

Antidiabetic Effects of Adding a DPP-4 Inhibitor to Pre-Existing Treatment With an Incretin Mimetic in Patients With T2D

Phase 3
Completed
Conditions
Type 2 Diabetes
Interventions
Drug: Placebo
Other: Mixed meal test
First Posted Date
2013-09-09
Last Posted Date
2017-01-30
Lead Sponsor
Michael A. Nauck
Target Recruit Count
16
Registration Number
NCT01937598
Locations
πŸ‡©πŸ‡ͺ

Diabeteszentrum Bad Lauterberg, Bad Lauterberg, Germany

Quantification of the Dipeptidyl Peptidase (DPP)-4 Inhibition-mediated Enhancement of the Activity of the Entero-insular Axis

Phase 2
Completed
Conditions
Diabetes
Interventions
First Posted Date
2008-05-23
Last Posted Date
2015-12-18
Lead Sponsor
Michael A. Nauck
Target Recruit Count
20
Registration Number
NCT00683735
Locations
πŸ‡©πŸ‡ͺ

Diabeteszentrum Bad Lauterberg, Bad Lauterberg, Germany

Β© Copyright 2025. All Rights Reserved by MedPath